Skip to main content

Advertisement

SpringerLink
Log in

25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gerosa M, Chighizola C, Meroni PL (2008) Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). Intern Emerg Med 3:201–203

    Article  PubMed  Google Scholar 

  2. Finazzi G (2008) Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No. Intern Emerg Med 3:197–200

    Article  PubMed  Google Scholar 

  3. Edwards CJ, Hughes GRV (2008) Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol 18:119–124

    Article  PubMed  CAS  Google Scholar 

  4. Pierangeli SS, Chen PP, Raschi E et al (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236–250

    Article  PubMed  Google Scholar 

  5. Myakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  Google Scholar 

  6. Cervera R, Khamashta MA, Shoenfeld Y et al (2008) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann Rheum Dis [Epub ahead of print]

  7. Erkan D, Harrison MJ, Levy R et al (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome. Arthritis Rheum 56:2382–2391

    Article  PubMed  CAS  Google Scholar 

  8. Ruffatti A, Del Ross T, Ciprian M et al (2008) Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study. Ann Rheum Dis [Epub ahead of print]

  9. Nuzzo M, Ceribelli A, Allegri F et al (2007) First thrombotic event in patients with obstetric APS. Clin Exp Rheum 25:25S–26S

    Google Scholar 

  10. Erkan D, Patel S, Nuzzo M et al (2008) Management of the controversial aspects of the antiphospholipid sindrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 47:iii23–iii27

    Article  Google Scholar 

  11. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:381S–453S

    Article  PubMed  CAS  Google Scholar 

  12. Galli M, Reber G, de Moerloose P, de Groot PG (2008) Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 6:399–401

    Article  PubMed  CAS  Google Scholar 

  13. Finazzi G, Brancaccio V, Moia M et al (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four-year prospective study from the Italian registry. Am J Med 100:530–536

    Article  PubMed  CAS  Google Scholar 

  14. Ginsburg KS, Liang MH, Newcomer L et al (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997–1002

    PubMed  CAS  Google Scholar 

  15. Vaarala O, Mänttäri M, Manninen V et al (1995) Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 91:23–27

    PubMed  CAS  Google Scholar 

  16. Shoenfeld Y, Meroni PL, Cervera R (2008) Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 67:438–442

    Article  PubMed  CAS  Google Scholar 

  17. Roubey RAS (2003) New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations. Arthritis Rheum 48:3004–3008

    Article  PubMed  CAS  Google Scholar 

  18. Rand JH, Wu XX, Quinn AS et al (2008) Hydroxychloroquine directly reduces the binding of antiphospholipid antibody- β2-glycoprotein I complexes to phospholipid bilayers. Blood 112:1687–1695

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

The authors did consultancies for Phadia, Diasorin and BioRad in 2008.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy

    Laura Andreoli & Angela Tincani

Authors
  1. Laura Andreoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Tincani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela Tincani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andreoli, L., Tincani, A. 25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. Intern Emerg Med 4, 165–167 (2009). https://doi.org/10.1007/s11739-008-0222-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0222-3

Keywords

Search

Navigation